Sustained Ventricular Tachycardia clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Cryoablation for Monomorphic Ventricular Tachycardia
open to eligible people ages 18 years and up
The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)
at UCSF
Our lead scientists for Sustained Ventricular Tachycardia research studies include Edward Gerstenfeld, MD.
Last updated: